Empowering Pharmacists: Enhancing RSV Knowledge and Vaccine Advocacy : Episode 2

Non-adjuvant RSV Vaccine in Older Adults

June 25, 2024

Opinion

Video

An RSV medical expert provides an overview of the RENOIR trial, which investigated the efficacy and safety of an adjuvanted RSV vaccine in adults aged 60 years and older, focusing on the vaccine's effectiveness in preventing RSV-associated lower respiratory tract infections and presenting other crucial findings from the study.

EP: 1.Adjuvant RSV Vaccine in Older Adults

Now Viewing

EP: 2.Non-adjuvant RSV Vaccine in Older Adults

The RENOIR trial studied the safety and efficacy of non-adjuvanted vaccine in adults aged 60 years or older. What interim results were significant from this trial leading to the indication of the vaccine for this population?
1. Efficacy at preventing RSV-associated lower respiratory tract infections
2. Adverse effects
3. Trial limitations